18
The Case for Action Colorectal Cancer in the Northeast Mark Hartman Vice President Cancer Services and Medical Imaging, HSN; Regional Vice President Northeast, Cancer Care Ontario

Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Embed Size (px)

DESCRIPTION

Mark Hartman's opening presentation for the 2013 Regional Oncology Conference.

Citation preview

Page 1: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

The Case for Action

Colorectal Cancer in the Northeast

Mark Hartman Vice President Cancer Services and Medical Imaging, HSN;

Regional Vice President Northeast, Cancer Care Ontario

Page 2: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Faculty/Presenter Disclosure

Faculty: Mark Hartman

Relationships with commercial interests:•Grants/Research Support: None•Speakers Bureau/Honoraria: None•Consulting Fees: None

Page 3: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

The Colorectal Cancer Burden

Incidence: 2nd in NE

Data source: Cancer Care Ontario (Ontario Cancer Registry, 2010 for SEER*Stat Release 8 Feb. 2011).

Page 4: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

The Colorectal Cancer Burden

Deaths: 2nd in NE

Data source: Cancer Care Ontario (Ontario Cancer Registry, 2010 for SEER*Stat Release 8 Feb. 2011).

Page 5: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

The Northeast

Highest Incidence in Ontario

55 vs 47.7 per 100,000

474 New Cases

180 Deaths

Page 6: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Stage at Diagnosis: An Opportunity

I

II

III

IV

50%

Estimated 5 yr

relative survival

5%

55%

96%

87%

Page 7: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Colorectal Screening

45%25%

Page 8: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Screening Follow Up

+ve FOBT(n=955) Colonoscopy(n=701)

27% no colonoscopy

within 6mo

Page 9: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Diagnosis in the Northeast

Pathology Turnaround Time:

85% with 2 weeks

FOBT +ve Colonoscopy:

81% within 8 weeks

+ve Family Hx Colonoscopy:

86% within 26 weeks

Page 10: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Radiation Treatment

Page 11: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Systemic Treatment

89%

Page 12: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Surgery and Pathology

<10%

Page 13: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Outcomes

NE=65%

Page 14: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Outcomes

Page 15: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Prevalence

NE~2550

Page 16: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Patient Experience

42%

Page 17: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

Summary

Foundational systems are in place

Standards are being established

Progress is being made

Many opportunities for improved outcomes and experiences

Page 18: Northeast Case for Action: Colorectal Cancer, Mr. Mark Hartman

References

• Cancer System Quality Index 2013: http://www.csqi.on.ca/cms/One.aspx?portalId=258922&pageId=274113

• INSIGHT ON COLORECTAL CANCER: News and information on colorectal cancer and screening in Ontario, volume seven, December 2008, Cancer Care Ontario

• ColonCancerCheck Program Report 2010, https://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=226298

• Cancer Statistics 2007, Cancer Care Ontario, https://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=8630